Theramex invests €10 million in Portugal

The pharmaceutical company intends to invest in the Portuguese women's health market, which represents around €120 million.

 

Theramex, a pharmaceutical company specialising in women’s health, wants to strengthen its presence in Portugal and over the next five years will invest around €10 million and create between 60 and 100 direct and indirect jobs, as well as opening offices in Lisbon and Porto in the next two years. By 2026, the pharmaceutical company expects to reach an annual turnover of €15 million.


Until now, Theramex’s presence in Portugal has been managed from an integrated Iberian perspective, from Madrid. But now the pharmaceutical company specialising in women’s health, with a special focus on contraception, menopause, osteoporosis and fertility, intends to invest in the Portuguese women’s health market, which represents approximately €120 million, according to figures provided by the company.


Source: CCIPV / AICEP